Insider trades
Tobin W. Juvenal, Chief Officer of Castle Biosciences CSTL, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 05/21.
Tobin W. Juvenal
Chief Commercial Officer
- Company
- Castle Biosciences CSTL
- First filing
- 23/03/03
- Trades
- 71 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$1.2M
- Last trade
- 05/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/12 | 03/16 | 20,863 sh | $25.24 | $526,582.12 | −19.4% | |
| Open-market sale | 25/12/11 | 25/12/15 | 13,200 sh | $37.48 | $494,736 | −13.2% | |
| Open-market sale10b5-1 plan | 25/11/20 | 25/11/24 | 4,693 sh | $35.58 | $166,976.94 | −5.3% | |
CSTL | Open-market sale10b5-1 plan · Amendment | 25/11/11–25/11/12 | 25/11/14 | 700 sh2 trades | $35.39avg. | $24,775 | −0.8% |
CSTL | Open-market sale10b5-1 plan | 25/11/11–25/11/12 | 25/11/13 | 700 sh2 trades | $35.39avg. | $24,775 | −0.8% |
| Open-market sale10b5-1 plan | 25/01/06 | 25/01/08 | 2,230 sh | $30.00 | $66,900 | −3.1% | |
| Open-market sale10b5-1 plan | 24/11/05 | 24/11/07 | 3,507 sh | $35.56 | $124,708.92 | −6.1% | |
| Open-market sale10b5-1 plan | 24/11/01 | 24/11/05 | 3,100 sh | $35.39 | $109,709 | −5.4% |